FDA Warning Letters for Alzheimer’s Supplement Claims
On February 11, 2019, the U.S. Food & Drug Administration (“FDA”) published a warning to the public entitled “FDA takes…
On February 11, 2019, the U.S. Food & Drug Administration (“FDA”) published a warning to the public entitled “FDA takes…
On March 2, 2018, the U.S. Food & Drug Administration (“FDA”) published a warning to the public entitled “FDA warns…
The U.S. Food and Drug Administration (“FDA”) has recently been issuing letters to companies that are distinct from traditional FDA…
FDA Regulation of Cosmetics Products Importers introducing cosmetic products into the United States must be mindful of FDA regulations, which…
A U.S. District judge New Jersey has ruled in United States v. Bayer Corporation that Bayer will not be held…
On April 16, 2015, U.S. Marshals seized what the U.S. Food & Drug Administration (“FDA”) classified as unapproved prescription drugs…
On March 31, 2015, Attorney Katherine Giannamore, of The Law Office of Katherine Giannamore, P.A., was interviewed by Ryan Nelson…
The difference between a product being marketed as a cosmetic and marketed as a drug can be a very thin…
On January 30, 2015, and at the request of the U.S. Food and Drug Administration (FDA), a federal judge granted…
On October 10, 2014, a federal judge from the U.S. District Court for the Southern District of Ohio sided with…